Evoke Pharma Inc (EVOK)
0.4788
-0.07
(-12.79%)
USD |
NASDAQ |
Apr 18, 16:00
0.5037
+0.02
(+5.20%)
After-Hours: 20:00
Evoke Pharma Debt to Equity Ratio: -1.938 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.938 |
| September 30, 2023 | -5.722 |
| June 30, 2023 | 9.287 |
| March 31, 2023 | 2.352 |
| December 31, 2022 | 1.224 |
| September 30, 2022 | 0.9037 |
| June 30, 2022 | 0.6953 |
| Date | Value |
|---|---|
| March 31, 2022 | 2.585 |
| December 31, 2021 | 1.406 |
| September 30, 2021 | 1.048 |
| June 30, 2021 | 0.8381 |
| March 31, 2021 | 0.6401 |
| December 31, 2020 | -1.588 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-5.722
Minimum
Sep 2023
9.287
Maximum
Jun 2023
0.9024
Average
0.9037
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Eton Pharmaceuticals Inc | 0.3476 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.068M |
| Total Liabilities (Quarterly) | 9.648M |
| Shareholders Equity (Quarterly) | -2.580M |
| Current Ratio | 2.249 |